Bazedoxifene 鹽酸鹽,Bazedoxifene hydrochloride

Bazedoxifene 鹽酸鹽|T6404|TargetMol

價(jià)格	￥492	￥1270	￥2300
包裝	1mg	5mg	10mg

最小起訂量	1mg
發(fā)貨地	上海
更新日期	2024-12-12

QQ交談微信洽談

產(chǎn)品詳情

中文名稱:Bazedoxifene 鹽酸鹽	英文名稱:Bazedoxifene hydrochloride
CAS:198480-56-7	品牌: TargetMol
產(chǎn)地: 美國	保存條件: store at low temperature,keep away from direct sunlight \| Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice.
純度規(guī)格: 98.74%	產(chǎn)品類別: 抑制劑
貨號(hào): T6404

Product Introduction

Bioactivity

名稱	Bazedoxifene hydrochloride
描述	Bazedoxifene hydrochloride (TSE 424 hydrochloride) is an orally active, selective, and potent estrogen receptor modulator (SERM) that crosses the blood-brain barrier and is an inhibitor of IL-6/GP130 protein interactions with high affinity for ERα and ERβ. It has a high affinity for ERα and ERβ and can be used to study postmenopausal osteoporosis and vasodilator-related diseases.
細(xì)胞實(shí)驗(yàn)	For the proliferation assay, cells are plated at 20,000 cells/well in a 24-well plate in DMEM/F12 (50:50) (phenol red-free) with 10% charcoal/dextran-treated FBS and 1 × GlutaMAX-1. After overnight incubation, the medium is aspirated and treatments in DMEM/F12 (50:50) (phenol red-free) with 2% charcoal/dextran-treated FBS and 1 × GlutaMAX-1 are added to the wells. Each plate has a vehicle (baseline proliferation) and treatments. Treatments included 10 pM 17β-estradiol determined to be the EC80 for 17β-estradiol and 17β-estradiol in combination with six concentrations of BZA. Treatments from d 1 are renewed on d 3 and d 6 by aspirating medium from wells and replacing with fresh medium and treatments. On d 7, cells are detached from the plate using trypsin-EDTA and counted using a Multisizer II.(Only for Reference)
激酶實(shí)驗(yàn)	Ligand binding competition experiments: Test compounds are initially solubilized in DMSO and the final concentration of DMSO in the binding assay is ≤ 1%. Eight dilutions of each test compound are used as an unlabelled competitor for [3H]17β-estradiol. Typically, a set of compound dilutions would be tested simultaneously on human, rat and mouse ER-α and ER-β. The results are plotted as measured DPM vs. concentration of test compound. For dose-response curve fitting, a four parameter logistic model on the transformed, weighted data are fit and the IC50 is defined as the concentration of compound decreasing maximum [3H]estradiol binding by 50%. For active compounds, the IC50 is determined at least three times. It should be noted that IC50 values are not direct measures of a ligand's affinity for the receptor. Rather, they can only be compared as relative values, in this case to 17β-estradiol.
體外活性	在 AsPC-1 細(xì)胞中，Bazedoxifene hydrochloride（10 μM-20 μM；2 小時(shí)）能夠抑制由 IL-6、IL-11 或 OSM（各50 ng/mL）誘導(dǎo)的 STAT3 磷酸化[2]。
體內(nèi)活性	在 6 周齡的雌性無胸腺裸鼠中，Bazedoxifene hydrochloride（劑量為5 mg/kg；通過口服灌胃，每日一次，持續(xù) 18 天）被用于抑制胰腺癌異種移植瘤的生長，并在腫瘤細(xì)胞中誘導(dǎo)凋亡[2]。
存儲(chǔ)條件	store at low temperature,keep away from direct sunlight \| Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice.
溶解度	H2O : <1 mg/mL Ethanol : <1 mg/mL DMSO : 93 mg/mL (183.4 mM)
關(guān)鍵字	TSE-424 \| TSE424 \| TSE 424 \| STAT3 \| SERM \| selective \| receptor \| protein-protein \| modulator \| interactions \| IL-6/GP130 \| Estrogen Receptor/ERR \| estrogen \| ERβ \| ERα \| Bazedoxifene HCl \| Bazedoxifene
相關(guān)產(chǎn)品	Estradiol \| Sodium Thiocyanate \| Amlexanox \| Diallyl disulfide \| Melatonin \| Mifepristone \| Inosine pranobex \| Dexamethasone \| Ethisterone \| Tamoxifen \| Kaempferol \| Disulfiram
相關(guān)庫	抑制劑庫 \| 經(jīng)典已知活性庫 \| 抗癌化合物庫 \| 已知活性化合物庫 \| FDA上市及藥典收錄分子庫 \| 上市藥物庫 \| FDA 上市藥物庫 \| 免疫/炎癥分子化合物庫 \| 口服活性化合物庫 \| 藥物功能重定位化合物庫

關(guān)鍵字： WAY 140424 hydrochloride|||TSE-424 hydrochloride|||TSE424 hydrochloride|||TSE 424 hydrochloride|TargetMol

公司簡介

TargetMol Chemicals Inc. 總部位于馬薩諸塞州波士頓，致力于為全球生化領(lǐng)域科學(xué)家的研究提供專業(yè)的產(chǎn)品和服務(wù)。TargetMol?品牌的客戶群分布于40多個(gè)國家和地區(qū)，已發(fā)展成為全球知名的化合物庫和小分子化合物研究供應(yīng)商。 TargetMol?可提供160多種滿足不同需求的化合物庫，以及多種類型的生化試劑產(chǎn)品，包括12000多種抑制劑、16000多種天然產(chǎn)物和各類多肽、抗體、生命科學(xué)試劑盒等，此外，我們還建設(shè)有CADD（計(jì)算機(jī)輔助藥物設(shè)計(jì)）研究中心、藥理實(shí)驗(yàn)室、藥化合成平臺(tái)三大技術(shù)中心，全方位滿足客戶的定制需求。憑借我們優(yōu)質(zhì)的產(chǎn)品和服務(wù)、快速高效的全球供應(yīng)鏈和專業(yè)的技術(shù)支持，我們將有效幫助您縮短研發(fā)周期，取得更成功的結(jié)果。

成立日期	2013-04-18 （12年）	注冊資本	566.265100萬人民幣
員工人數(shù)	100-500人	年?duì)I業(yè)額	￥ 1億以上
主營行業(yè)	天然產(chǎn)物,生化試劑,分子生物學(xué),分子砌塊,生物技術(shù)服務(wù)	經(jīng)營模式	貿(mào)易,工廠,試劑,定制,服務(wù)

TargetMol中國（陶術(shù)生物）

VIP 3年

公司成立：12年
注冊資本：566.265100萬人民幣
企業(yè)類型：有限責(zé)任公司(自然人投資或控股)
主營產(chǎn)品：小分子抑制劑、藥物篩選化合物庫、藥物篩選等
公司地址：靜安區(qū)江場三路238號(hào)8樓

進(jìn)入店鋪

詢盤

店內(nèi)推薦

化合物 BET bromodomain inhibitor|T2072|TargetMol

￥346

醋酸阿托西班|T5148|TargetMol

￥248

化合物 2-Amino-6-chloropurine-9-(2’-O-propargyl)riboside|TNU0206|TargetMol

詢價(jià)